Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 288-312-5 | CAS number: 85711-52-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- other: read across from analogue substance
- Adequacy of study:
- key study
- Study period:
- 28 September 2015 - 27 October 2015
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Amides, from diethylenetriamine and hydrogenated palm oil
- EC Number:
- 810-543-2
- Cas Number:
- 1618093-67-6
- Molecular formula:
- n/a
- IUPAC Name:
- Amides, from diethylenetriamine and hydrogenated palm oil
- Test material form:
- solid: compact
- Details on test material:
- - Name of test material (as cited in study report): Amidoamine (UVCB)
- Substance type: Amidoamine
- Chemical name: Glycerides, C14-20, reaction products with diethylenetriamine (preliminary naming)/Amides, from diethylenetriamine and hydrogenated palm oil
- CAS 85409-11-6/1618093-67-6
- Physical state: pale yellowish solid at 20 °C
- Batch No.: K8 4309 L481
- Expiry date of batch: 09 March 2017
- Purity: 100 % (UVCB)
- Storage condition of test material: Room temperature, protected from light
- Stability: stable under test conditions
Constituent 1
- Specific details on test material used for the study:
- Test item without emulsifier was investigated.
Amidoamine (UVCB)
Pulcra ID: DE07_2014_012_BEL66 (amidoamine without emulsifier)
Physical state: pale yellowish solid at 20 °C
Batch No.: K8 4309 L481
Expiry date of batch: 09 March 2017
Purity: 100 % (UVCB)
Stability: stable under test conditions
Storage condition of test material: Room temperature, protected from light
Method
- Target gene:
- Salmonella typhimurium
Strains / Genotype
TA1537 / his C 3076; rfa-; uvrB-;
TA98 / his D 3052; rfa-; uvrB-;R-factor
TA1535 / his G 46; rfa-; uvrB-
TA100 / his G 46; rfa-; uvrB-;R-factor
Escherichia coli
Strain / Genotype
WP2uvrA / trp-; uvrA-
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix
- Test concentrations with justification for top dose:
- The test item was tested using the following method. The maximum concentration was 5000 µg/plate (the maximum recommended dose level). Eight concentrations of the test item (1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate) were assayed in triplicate against each tester strain, using the direct plate incorporation method.
The dose range used for Experiment 2 was determined by the results of Experiment 1 and was 1.5 to 5000 µg/plate.
Six test item concentrations were selected in Experiment 2 in order to achieve both four non-toxic dose levels and the potential toxic limit of the test item following the change in test methodology.
- Vehicle / solvent:
- The test item was considered to have formed the best doseable suspension in sterile distilled water (12.5 mg/mL), therefore, this solvent was selected as the vehicle.
Controls
- Untreated negative controls:
- yes
- Remarks:
- sterile distilled water
- Negative solvent / vehicle controls:
- yes
- Remarks:
- sterile distilled water
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- other: 2-Aminoanthracene (with metabolic activation), Benzo(a)pyrene (with metabolic activation)
- Details on test system and experimental conditions:
- The test item was tested using the following method. The maximum concentration was 5000 µg/plate (the maximum recommended dose level). Eight concentrations of the test item (1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate) were assayed in triplicate against each tester strain, using the direct plate incorporation method. All of the plates were incubated at 37 ± 3 °C for approximately 48 hours and scored for the presence of revertant colonies using an automated colony counting system. The plates were viewed microscopically for evidence of thinning (toxicity). A number of manual counts were performed, predominantly due to colonies spreading and artefacts on the plates, thus distorting the actual plate count.
- Evaluation criteria:
- There are several criteria for determining a positive result. Any, one, or all of the following can be used to determine the overall result of the study:
1. A dose-related increase in mutant frequency over the dose range tested (De Serres and Shelby, 1979).
2. A reproducible increase at one or more concentrations.
3. Biological relevance against in-house historical control ranges.
4. Statistical analysis of data as determined by UKEMS (Mahon et al., 1989).
5. Fold increase greater than two times the concurrent solvent control for any tester strain (especially if accompanied by an out-of-historical range response (Cariello and Piegorsch, 1996)).
A test item will be considered non-mutagenic (negative) in the test system if the above criteria are not met.
Although most experiments will give clear positive or negative results, in some instances the data generated will prohibit making a definite judgment about test item activity. Results of this type will be reported as equivocal. - Statistics:
- Statistical analysis of data as determined by UKEMS (Mahon et al., 1989).
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Experiment 1 and 2 - plate incorporation test and in the preincubation test.
The S9 Microsomal fraction was prepared in-house from male rats induced with Phenobarbitone/beta-Naphthoflavone at 80/100 mg/kg/day, orally, for 3 days prior to preparation on day 4. The S9 homogenate was produced by homogenizing the liver in a 0.15M KCl solution (1g liver to 3 mL KCl) followed by
centrifugation at 9000 g. The protein content of the resultant supernatant was adjusted to 20 mg/mL. Aliquots of the supernatant were frozen and stored at approximately -196 °C. Prior to use, each batch of S9 was tested for its capability to activate known mutagens in the Ames test. - Remarks on result:
- other:
- Remarks:
- Experiment 1 & 2
Any other information on results incl. tables
Exemplary results of Ames-Test: Plate incorporation - number of revertants (mean) +/- SD for all tested doses with and without metabolic activation.
Experiment 1 – Without Metabolic Activation
S9-Mix (-) |
Dose Level Per Plate |
Number of revertants (mean) +/- SD | ||||
|
Base-pair substitution strains |
Frameshift strains |
||||
|
|
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
|
Solvent Control (Water) |
119 107 119 (115) 6.9# |
11 17 15 (14) 3.1 |
21 21 21 (21) 0.0 |
19 12 17 (16) 3.6 |
7 15 8 (10) 4.4 |
|
1,5 µg |
93 103 81 (92) 11.0 |
16 12 9 (12) 3.5 |
25 19 32 (25) 6.5 |
23 19 21 (21) 2.0 |
15 7 17 (13) 5.3 |
|
5 µg |
97 97 114 (103) 9.8 |
14 10 9 (11) 2.6 |
27 28 15 (23) 7.2 |
15 12 19 (15) 3.5 |
12 7 16 (12) 4.5 |
|
15 µg |
94 126 110 (110) 16.0 |
14 12 13 (13) 1.0 |
19 24 32 (25) 6.6 |
28 11 11 (17) 9.8 |
9 15 7 (10) 4.2 |
|
50 µg |
117 129 114 (120) 7.9 |
9 9 10 (9) 0.6 |
17 21 19 (19) 2.0 |
17 20 23 (20) 3.0 |
11 11 11 (11) 0.0 |
|
150 µg |
94 112 118 (108) 12.5 |
14 11 10 (12) 2.1 |
16 21 24 (20) 4.0 |
13 12 27 (17) 8.4 |
7 9 12 (9) 2.5 |
|
500 µg |
103 95 107 (102) 6.1 |
8 10 16 (11) 4.2 |
32 36 17 (28) 10.0 |
21 25 12 (19) 6.7 |
9 12 15 (12) 3.0 |
|
1500 µg |
109 91 110 (103) 10.7 |
6 12 10 (9) 3.1 |
23 13 25 (20) 6.4 |
11 8 24 (14) 8.5 |
5 9 12 (9) 3.5 |
|
5000 µg |
94 P 115 P 124 P (111) 15.4 |
9 P 12 P 5 P (9) 3.5 |
29 P 36 P 26 P (30) 5.1 |
13 P 13 P 23 P (16) 5.8 |
8 P 4 P 11 P (8) 3.5 |
Positive controls S9-Mix (-) |
Name |
ENNG |
ENNG |
ENNG |
4NQO |
9AA |
|
Dose Level |
3 µg |
5 µg |
2 µg |
0.2 µg |
80 µg |
|
No. of Revertants |
386 392 444 (407) 31.9 |
298 358 372 (343) 39.3 |
579 521 476 (525) 51.6 |
192 210 178 (193) 16.0 |
964 869 671 (835) 149.5 |
† Experimental procedure repeated at a later date due to poor colony growth in the original test
ENNG N-ethyl-N'-nitro-N-nitrosoguanidine
4NQO 4-Nitroquinoline-1-oxide
9AA 9-Aminoacridine
P Test item precipitate
# Standard deviation
Test Results: Experiment 1 – With Metabolic Activation
S9-Mix (+) |
Dose Level Per Plate |
Number of revertants (mean) +/- SD | ||||
|
Base-pair substitution strains |
Frameshift strains |
||||
|
|
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
|
Solvent Control (Water) |
110 115 124 (116) 7.1# |
12 11 8 (10) 2.1 |
20 28 29 (26) 4.9 |
16 20 16 (17) 2.3 |
8 9 13 (10) 2.6 |
|
1,5 µg |
117 125 119 (120) 4.2 |
8 12 10 (10) 2.0 |
23 32 25 (27) 4.7 |
15 15 23 (18) 4.6 |
7 17 12 (12) 5.0 |
|
5 µg |
118 106 126 (117) 10.1 |
13 9 5 (9) 4.0 |
17 36 25 (26) 9.5 |
11 29 19 (20) 9.0 |
15 7 15 (12) 4.6 |
|
15 µg |
114 129 121 (121) 7.5 |
17 9 9 (12) 4.6 |
29 29 16 (25) 7.5 |
16 28 29 (24) 7.2 |
8 11 7 (9) 2.1 |
|
50 µg |
82 122 119 (108) 22.3 |
8 8 8 (8) 0.0 |
31 23 29 (28) 4.2 |
23 19 15 (19) 4.0 |
9 13 13 (12) 2.3 |
|
150 µg |
91 97 94 (94) 3.0 |
11 11 12 (11) 0.6 |
28 20 23 (24) 4.0 |
28 27 19 (25) 4.9 |
17 19 17 (18) 1.2 |
|
500 µg |
106 106 99 (104) 4.0 |
8 7 12 (9) 2.6 |
33 39 27 (33) 6.0 |
20 21 25 (22) 2.6 |
13 8 7 (9) 3.2 |
|
1500 µg |
117 97 90 (101) 14.0 |
10 11 7 (9) 2.1 |
27 27 17 (24) 5.8 |
28 17 20 (22) 5.7 |
5 13 11 (10) 4.2 |
|
5000 µg |
102 P 98 P 97 P (99) 2.6 |
11 P 7 P 5 P (8) 3.1 |
25 P 28 P 20 P (24) 4.0 |
16 P 32 P 33 P (27) 9.5 |
16 P 15 P 9 P (13) 3.8 |
Positive controls S9-Mix (+) |
Name |
2AA |
2AA |
2AA |
BP |
2AA |
|
Dose Level |
1 µg |
2 µg |
10 µg |
5 µg |
2 µg |
|
No. of Revertants |
719 647 540 (635) 90.1 |
243 221 215 (226) 14.7 |
372 351 405 (376) 27.2 |
195 183 207 (195) 12.0 |
342 376 341 (353) 19.9 |
† Experimental procedure repeated at a later date due to poor colony growth in the original test
BP Benzo(a)pyrene
2AA 2-Aminoanthracene
P Test item precipitate
# Standard deviation
Applicant's summary and conclusion
- Conclusions:
- The test item was considered to be non-mutagenic under the conditions of this test.
- Executive summary:
In a key Ames test performed with registered substance, the test item was examined in the four Salmonella typhimurium strains TA98, TA100, TA1535 and TA1537 and one Escherichia coli strain in two independent experiments, each carried out without and with metabolic activation (P Thompson, 2016). The first experiment was carried out as a plate incorporation test and the second as a preincubation test. The test item was suspended in sterile distilled water. Sterile distilled water was used as vehicle control. In a preliminary test, no cytotoxicity was noted at concentrations up to 5000 µg test item/plate, hence 5000 µg test item/plate were chosen as top concentration for the main study in the plate incorporation test and in the preincubation test. In the plate incorporation test and in the preincubation test, each carried out without and with metabolic activation, no increase in revertant colony numbers as compared with control counts was observed up to a concentration of 5000 µg test item/plate, in any of the 5 test strains. A test item precipitate (powdery in appearance) was observed at 5000 µg/plate in the first mutation test (plate incorporation method) and initially from 500 µg/plate in the second mutation test (pre-incubation method), this observation did not prevent the scoring of revertant colonies. In conclusion, negative results were obtained for both bacterial mutagenicity studies tested both with and wihtout metbabolic activation.
There were no significant increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 1 (plate incorporation method). Similarly, no significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 2 (pre-incubation method).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.